[Does noradrenaline also annul the anti-atherogenic action of hepatic cirrhosis].
D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology* / Q000517:prevention & control; D002252:Carbon Tetrachloride Poisoning / Q000150:complications*; D056486:Chemical and Drug Induced Liver Injury / Q000150:complications*; D002791:Cholesterol, Dietary; D004036:Diet, Atherogenic; D008106:Liver Cirrhosis, Experimental / Q000150:complications*; D009638:Norepinephrine / Q000494:pharmacology*; D011817:Rabbits
D002791:Cholesterol, Dietary; D009638:Norepinephrine
Annulla la noradrenalina anche l'azione antiaterogena della cirrosi epatica?